As of April 16, 2025, Marinus Pharmaceuticals (MRNS) has a market cap of $30.370 million USD. According to our data, Marinus Pharmaceuticals is ranked No.8354 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $30.37 M |
2.80%
|
Dec 31, 2024 | $29.54 M |
-95.08%
|
Dec 29, 2023 | $0.60 B |
173.12%
|
Dec 30, 2022 | $0.22 B |
-66.50%
|
Dec 31, 2021 | $0.66 B |
-2.62%
|
Dec 31, 2020 | $0.67 B |
41.20%
|
Dec 31, 2019 | $0.48 B |
-24.74%
|
Dec 31, 2018 | $0.63 B |
-64.83%
|
Dec 29, 2017 | $1.80 B |
707.92%
|
Dec 30, 2016 | $0.22 B |
-86.78%
|
Dec 31, 2015 | $1.69 B |
-27.72%
|
Dec 31, 2014 | $2.33 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
![]() Ireland
|
![]() Sage Therapeutics
SAGE
|
$0.46 B |
0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.32 B |
0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$3.70 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Amicus Therapeutics
FOLD
|
$2.12 B |
-0.000 M
|
![]() USA
|
![]() Neurocrine Biosciences
NBIX
|
$9.51 B |
0.000 M
|
![]() USA
|
![]() Catalyst Pharmaceuticals
CPRX
|
$2.83 B |
-0.000 M
|
![]() USA
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.76 B |
-0.000 M
|
![]() USA
|
![]() Ovid Therapeutics
OVID
|
$20.36 M |
0.000 M
|
![]() USA
|
Market Cap | = | MRNS Stock Price | * | MRNS Shares Outstanding |
= | $0.55 | * | 55.22 M | |
= | $30.37 M |